ATZORI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.970
EU - Europa 245
AS - Asia 111
SA - Sud America 1
Totale 2.327
Nazione #
US - Stati Uniti d'America 1.968
SG - Singapore 68
IT - Italia 48
CN - Cina 34
SE - Svezia 29
IE - Irlanda 28
UA - Ucraina 24
FR - Francia 22
DE - Germania 21
RU - Federazione Russa 21
GB - Regno Unito 16
NL - Olanda 16
PL - Polonia 10
FI - Finlandia 4
ID - Indonesia 4
AT - Austria 2
CA - Canada 2
KR - Corea 2
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 2.327
Città #
Wilmington 501
Houston 491
Woodbridge 470
Fairfield 93
Chandler 65
Ashburn 62
Singapore 59
Ann Arbor 30
Seattle 30
Rome 27
Cambridge 25
Dublin 22
New York 20
Medford 14
Santa Clara 14
Dearborn 13
Beijing 10
Kraków 10
Jacksonville 9
Lawrence 7
Zhengzhou 7
Center 5
Palo Alto 5
Shanghai 5
Boardman 4
Jakarta 4
London 4
Moscow 4
Guidonia Montecelio 3
Munich 3
Paris 3
Washington 3
Civitavecchia 2
Cremona 2
Del Norte 2
Dongguan 2
Frankfurt am Main 2
Hefei 2
Mülheim 2
Naples 2
Phoenix 2
San Diego 2
Scottsdale 2
Vienna 2
Acton 1
Brno 1
Calgary 1
Carrara 1
Chisinau 1
Council Bluffs 1
Dong Ket 1
Genoa 1
Guangzhou 1
Helsinki 1
Hounslow 1
Islington 1
Los Gatos 1
Milan 1
Saint Petersburg 1
Salt Lake City 1
San Mateo 1
Seoul 1
Sofia 1
Stockholm 1
Taipei 1
Taizhou 1
Toronto 1
Wernigerode 1
Xingtai 1
Zibo 1
Totale 2.072
Nome #
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth 414
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding 362
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding 356
Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells. 310
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. 302
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. 293
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib 180
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor 43
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose 42
Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential 36
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors 30
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research 14
Totale 2.382
Categoria #
all - tutte 6.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 0 61 63 59 65 53 32 35
2020/2021389 36 39 38 72 30 31 34 46 11 29 19 4
2021/202278 4 8 11 3 0 4 4 4 8 8 10 14
2022/2023153 11 14 6 26 5 36 17 5 12 0 13 8
2023/2024103 7 3 5 5 12 32 7 1 4 6 14 7
2024/2025162 15 55 34 24 19 15 0 0 0 0 0 0
Totale 2.382